A Study of CIN-107 in Patients With Uncontrolled Hypertension Receiving 1 Antihypertensive Agent
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of
multiple dose strengths of CIN-107 in the treatment of patients with uncontrolled
hypertension who are currently taking 1 anti-hypertensive medication